About Linear Diagnostics
Linear Diagnostics is a company based in Birmingham (United Kingdom) founded in 2011 by Matthew Hicks.. Linear Diagnostics has raised $4.08 million across 4 funding rounds from investors including Abingdon Health, British Business Bank and The University Of Birmingham. The company has 4 employees as of January 31, 2022. Linear Diagnostics offers products and services including Linear Dichroism Technology and EXPAR System. Linear Diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Birmingham, United Kingdom
- Employees 4 as on 31 Jan, 2022
- Founders Matthew Hicks
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Linear Diagnostics Limited
- Date of Incorporation 29 Mar, 2011
- Jurisdiction NOTTINGHAM, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.08 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Abingdon Health
& 6 more
-
Employee Count
4
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Linear Diagnostics
Linear Diagnostics offers a comprehensive portfolio of products and services, including Linear Dichroism Technology and EXPAR System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables rapid and accurate detection of sexually transmitted infections at point of care.
Facilitates quick testing for multiple infectious diseases in under 15 minutes.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Linear Diagnostics
Linear Diagnostics has successfully raised a total of $4.08M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(24 May 2017)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - Linear Diagnostics | Valuation |
investors |
|
| Feb, 2021 | Amount | Seed - Linear Diagnostics | Valuation | Midven | |
| Sep, 2019 | Amount | Seed - Linear Diagnostics | Valuation | Midven |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Linear Diagnostics
Linear Diagnostics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Abingdon Health, British Business Bank and The University Of Birmingham. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage UK companies are invested in by Midven.
|
Founded Year | Domain | Location | |
|
Investment funding is provided to support Midlands SMEs growth.
|
Founded Year | Domain | Location | |
|
Early-stage innovations are funded by UKI2S across key sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Linear Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Linear Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Linear Diagnostics Comparisons
Competitors of Linear Diagnostics
Linear Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Linear Diagnostics
Frequently Asked Questions about Linear Diagnostics
When was Linear Diagnostics founded?
Linear Diagnostics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Where is Linear Diagnostics located?
Linear Diagnostics is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Who is the current CEO of Linear Diagnostics?
Brendan Farrell is the current CEO of Linear Diagnostics.
Is Linear Diagnostics a funded company?
Linear Diagnostics is a funded company, having raised a total of $4.08M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.57M, raised on May 24, 2017.
How many employees does Linear Diagnostics have?
As of Jan 31, 2022, the latest employee count at Linear Diagnostics is 4.
What does Linear Diagnostics do?
Linear Diagnostics was founded in 2011 in Birmingham, United Kingdom, within the biotechnology sector. Molecular diagnostic tests for sexually transmitted infections are developed, focusing on Chlamydia trachomatis and Neisseria gonorrhoeae. An optical system that integrates linear dichroism with disposable cartridges and instruments is utilized. Gene sequences are detected through this dual-test approach, supporting clinical diagnostics in the medical field.
Who are the top competitors of Linear Diagnostics?
Linear Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Linear Diagnostics offer?
Linear Diagnostics offers Linear Dichroism Technology and EXPAR System.
Who are Linear Diagnostics's investors?
Linear Diagnostics has 7 investors. Key investors include Abingdon Health, British Business Bank, The University Of Birmingham, Future Planet Capital Regional, and NIHR.
What is Linear Diagnostics's valuation?
The valuation of Linear Diagnostics is $2.61M as of Sep 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.